The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+16.3% to $110.50
Predicted High$110.50at 6 months
Predicted Low$96.20in 2 weeks
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 15, 2026 12:41 am
Bull
OKE trends higher to
$110.50
(+16.3% from $94.99)
by Feb 2027.
ride-then-fade
ThesisOKE has real value-gap upside ($186 fair vs $95), a risk-on tape, and an AI-data-center demand narrative that supports near-term drift higher. But value convergence in midstream is slow, negative beta means it lags a hot tape, and quality/value composite scores are weak - so I expect gradual grind toward the deterministic ~$111 endpoint, not a full re-rate.
Invalidated ifBreak below $88 support or loss of risk-on regime; conversely a decisive close above $105 accelerates the path.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $94.99 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 15, 2026
—
$94.99at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 29, 2026
$89.32–$100.66typical range · internal point $96.20
—
±6.0%
7/10
Risk-on tape and AI-datacenter hook sustain drift
1 month
Sep 15, 2026
$86.77–$103.21typical range · internal point $98.10
—
±8.7%
6/10
Sentiment tailwind continues, no earnings catalyst
2 months
Oct 15, 2026
$100.75
—
+6.1%
5/10
Value gap begins to attract slow-money bid
3 months
Nov 15, 2026
$103.50
—
+9.0%
5/10
Q3 print likely, EPS beat history supportive
4 months
Dec 15, 2026
$106.00
—
+11.6%
4/10
Year-end midstream yield chase into distributions
5 months
Jan 15, 2027
$108.25
—
+14.0%
4/10
Value convergence continues, negative beta caps upside
6 months
Feb 15, 2027
$110.50
—
+16.3%
3/10
Approaches deterministic endpoint, momentum fades
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$111.14
(+17.0%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.